Over 90 Total Lots Up For Auction at One Location - WA 04/08

The Neurotech Industry Investing and Partnering Conference 2009

by Lynn Shapiro, Writer | March 27, 2009
Moderator: Dan O'Connell, Managing Partner, NeuroVentures Capital

Neuroregeneration and Stem Cells:
Deborah Eppstein, President and CEO, Q Therapeutics
Andres Haegerstrand, Chief Scientific Officer, NeuroNova
stats
DOTmed text ad

Reveal Mobi Pro now available for sale in the US

Reveal Mobi Pro integrates the Reveal 35C detector with SpectralDR technology into a modern mobile X-ray solution. Mobi Pro allows for simultaneous acquisition of conventional & dual-energy images with a single exposure. Contact us for a demo at no cost.

stats

Jonathan Kil, President and CEO, Sound Pharmaceuticals
Martin McGlynn, President and CEO, StemCells, Inc.
Session Chair: Frank Eeckman, NeuroInsights, NIO

NeuroVaccines, The Use of Vaccines in Neurology and Psychiatry:
Raafat Fahim, President and CEO, Nabi
Mark Schwartz, President and CEO, Bayhill Therapeutics
Walter Schmidt, CEO, Affiris
Session Chair: Roger Quy, General Partner, Technology Partners

Traumatic Injury: Stroke, Traumatic Brain Injury, and Spinal Cord Injury:
Martin Dieck, President and CEO, Nfocus Neuromedical
Shawn Lunney, CEO, Neurolutions
Vincent Simmon, President and CEO, Xytis
Michael Singer, CEO, BrainScope
Session Chair: Teo Forcht Dagi, Partner, HLM Venture Partners

Neuroscience Translation, Tech Transfer and Collaboration Opportunities:
Jamie Driscoll, Chief of Research Services, NIMH
Jill Heemskerk, Acting Director, Office of Translational Research, NINDS
Joe Pancrazio, Program Director, Extramural, Repair & Plasticity Cluster,
NINDS Session Chair: Melissa Maderia, Technology Transfer Specialist, NINDS

And that's just for starters.

Back to HCB News